secwatch.observer — SEC 8-K summary
======================================

Issuer:     InnovAge Holding Corp. (INNV)
CIK:        0001834376
Form:       8-K
Filed at:   2022-02-09T23:59:59+00:00
Accession:  0001558370-22-000951
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InnovAge Q2 EPS $0.01 (down from $0.08); revenue +11.5% but profit and margins fall on medical normalization
--------------------------------------------------------------------------------

- Net income $1.1M vs $9.6M YoY; diluted EPS $0.01 vs $0.08.
- Revenue $175.4M, +11.5% YoY on census growth to ~7,050 (+6%).
- Center-level Contribution Margin $41.4M (-6.1%); margin 23.6% (down 4.4pp) on medical cost normalization and center re-openings.
- Adjusted EBITDA $14.8M vs $22.6M; margin 8.4% vs 14.5%.
- Company addressing audit deficiencies in Sacramento and Colorado; CEO notes COVID, labor pressures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834376/000155837022000951/0001558370-22-000951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834376/000155837022000951/tmb-20220209x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-000951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer